Piper Sandler lowered the firm’s price target on Xponential Fitness (XPOF) to $12 from $13 and keeps a Neutral rating on the shares following “solid” results. Piper acknowledged that efforts are going to take time to materialize and come with uncertainty around forward expectations that could inhibit more meaningful multiple expansion, the firm told investors in a research note. The firm added that it continues to remain on the sidelines until more significant improvements are made.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XPOF: